The global Ebstein’s anomaly market is on a significant growth trajectory, according to a recent report by Future Market Insights. The market, valued at USD 13.90 billion in 2023, is forecasted to surpass USD 30 billion by the end of 2033, marking a robust Compound Annual Growth Rate (CAGR) of 8% over the forecast period from 2023 to 2033.
Ebstein’s anomaly, a rare and serious congenital heart defect primarily affecting infants, is experiencing a noticeable increase in global prevalence. This rise in incidence is anticipated to drive the market’s substantial growth, as more focus and resources are directed towards diagnosis, treatment, and management of this complex condition.
Secure Your Sample Report with the Most Up-To-Date Market Information
The COVID-19 pandemic presented significant challenges to the treatment landscape of Ebstein’s anomaly. Disruptions in supply chain management and a slowdown in research and development activities due to funding constraints contributed to a temporary downturn in treatment options. However, as the world moves towards recovery, the forecast period offers promising prospects.
Furthermore, North America and Asia Pacific are two major regions contributing to the growth of the Ebstein’s market. This is owing to various government initiatives along with presence of advanced treatments in the region. A growing inclination towards hospitals has been observed due to the availability of varied nature of diagnosis and treatments. The amalgamation of technology and extensive research is expected to benefit the market in the upcoming years.
Key Takeaways from the Market Study:
- By end user, the hospital’s segment is expected to hold 50% of the market share in 2023 for Ebstein’s anomaly industry.
- By diagnosis, echocardiogram is expected to possess 33% market share for eibstien’s anomaly market in 2023.
- North America is expected to possess 40% market share for Ebstein’s anomaly industry in 2023.
- Asia Pacific Ebstein’s anomaly industry size is expected to possess 35% market share in 2023.
“Technologically advanced equipment to diagnose ebstein’s anomaly along with extensive research for manufacturing medication to treat the ailment is favoring market growth.” states a FMI analyst
Competitive Landscape:
Some of the key players in Ebstein’s anomaly industry are
- Abbott Vascular
- Boston Scientific Corporation
- Cordis Corporation
- Edwards Lifesciences
- Ge Healthcare
- Gore Medical
- Medtronic, Inc.,
- Numed, Inc.
Boost Your Business Strategy Instantly Access the Full Report
GE Healthcare, a key player in the Ebstein’s anomaly is focusing on undertaking research and collabroting with different research institutes to manufacture medications for Ebstein’s anomaly.
Boston Scientific Corporation another key player in Ebstein’s anomaly industry is focusing on integrating technology to diagnose the ailment at an early stage.
Key Segments Profiled in the Ebstein’s Anomaly Industry Survey:
Treatment:
- Medical
- Surgical Treatment
- Tricuspid Valve Repair
- Tricuspid Valve Replacement
- Closure of the Atrial Septal Defect
- Maze Procedure
Diagnosis:
- Echocardiogram
- Electrocardiogram
- Chest X-ray
- Cardiac MRI
- Holter Monitor
- Pulse Oximetry
- Exercise Stress Test
- Electrophysiology Study
- Cardiac Catheterization
End User:
- Hospitals & Surgical Centres
- Specialty Clinics
Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
